nodes	percent_of_prediction	percent_of_DWPC	metapath
Tacrolimus—ALB—Levothyroxine—hypothyroidism	0.128	0.206	CbGbCtD
Tacrolimus—ALB—Liothyronine—hypothyroidism	0.128	0.206	CbGbCtD
Tacrolimus—ALB—Liotrix—hypothyroidism	0.125	0.201	CbGbCtD
Tacrolimus—ABCB1—Liothyronine—hypothyroidism	0.0672	0.108	CbGbCtD
Tacrolimus—ABCB1—Levothyroxine—hypothyroidism	0.0672	0.108	CbGbCtD
Tacrolimus—ABCB1—Liotrix—hypothyroidism	0.0656	0.105	CbGbCtD
Tacrolimus—CYP3A4—Levothyroxine—hypothyroidism	0.0402	0.0647	CbGbCtD
Tacrolimus—Temperature intolerance—Dextrothyroxine—hypothyroidism	0.0114	0.0508	CcSEcCtD
Tacrolimus—Temperature intolerance—Levothyroxine—hypothyroidism	0.0114	0.0508	CcSEcCtD
Tacrolimus—Temperature intolerance—Liotrix—hypothyroidism	0.00836	0.0373	CcSEcCtD
Tacrolimus—Alkalosis—Liotrix—hypothyroidism	0.00684	0.0305	CcSEcCtD
Tacrolimus—PPP3CA—Amyotrophic lateral sclerosis (ALS)—NEFH—hypothyroidism	0.0066	0.206	CbGpPWpGaD
Tacrolimus—PPP3CA—Amyotrophic lateral sclerosis (ALS)—NEFM—hypothyroidism	0.00561	0.176	CbGpPWpGaD
Tacrolimus—ABCA5—adrenal cortex—hypothyroidism	0.00473	0.0389	CbGeAlD
Tacrolimus—ABCA5—heart—hypothyroidism	0.00458	0.0376	CbGeAlD
Tacrolimus—Hyperphosphataemia—Liotrix—hypothyroidism	0.00402	0.0179	CcSEcCtD
Tacrolimus—ABCA5—gonad—hypothyroidism	0.00392	0.0322	CbGeAlD
Tacrolimus—Renal tubular necrosis—Liotrix—hypothyroidism	0.00384	0.0172	CcSEcCtD
Tacrolimus—ABCA5—pituitary gland—hypothyroidism	0.00382	0.0314	CbGeAlD
Tacrolimus—ABCA5—adrenal gland—hypothyroidism	0.00342	0.0281	CbGeAlD
Tacrolimus—ABCA5—blood—hypothyroidism	0.00342	0.0281	CbGeAlD
Tacrolimus—ABCA5—thyroid gland—hypothyroidism	0.0033	0.0271	CbGeAlD
Tacrolimus—Phlebitis—Liothyronine—hypothyroidism	0.0032	0.0143	CcSEcCtD
Tacrolimus—PPP3CA—adrenal cortex—hypothyroidism	0.0032	0.0263	CbGeAlD
Tacrolimus—ABCA5—female gonad—hypothyroidism	0.00319	0.0262	CbGeAlD
Tacrolimus—PPP3CA—heart—hypothyroidism	0.00309	0.0254	CbGeAlD
Tacrolimus—Cardiac failure congestive—Liothyronine—hypothyroidism	0.00304	0.0136	CcSEcCtD
Tacrolimus—PPP3CA—cardiovascular system—hypothyroidism	0.00292	0.024	CbGeAlD
Tacrolimus—Abdominal bloating—Liotrix—hypothyroidism	0.00288	0.0129	CcSEcCtD
Tacrolimus—ABCA5—testis—hypothyroidism	0.00283	0.0232	CbGeAlD
Tacrolimus—ABCA5—liver—hypothyroidism	0.00267	0.0219	CbGeAlD
Tacrolimus—CYP3A4—urine—hypothyroidism	0.00262	0.0215	CbGeAlD
Tacrolimus—ABCA5—cerebellum—hypothyroidism	0.00261	0.0214	CbGeAlD
Tacrolimus—PPP3CA—pituitary gland—hypothyroidism	0.00258	0.0212	CbGeAlD
Tacrolimus—Acidosis—Liotrix—hypothyroidism	0.00248	0.0111	CcSEcCtD
Tacrolimus—Angina pectoris—Liothyronine—hypothyroidism	0.00232	0.0104	CcSEcCtD
Tacrolimus—PPP3CA—adrenal gland—hypothyroidism	0.00231	0.019	CbGeAlD
Tacrolimus—PPP3CA—blood—hypothyroidism	0.00231	0.019	CbGeAlD
Tacrolimus—MTOR—heart—hypothyroidism	0.00228	0.0188	CbGeAlD
Tacrolimus—PPP3CA—Amyotrophic lateral sclerosis (ALS)—NEFL—hypothyroidism	0.00223	0.0699	CbGpPWpGaD
Tacrolimus—PPP3CA—thyroid gland—hypothyroidism	0.00223	0.0183	CbGeAlD
Tacrolimus—Fluid overload—Liotrix—hypothyroidism	0.00221	0.00986	CcSEcCtD
Tacrolimus—MTOR—cardiovascular system—hypothyroidism	0.00215	0.0177	CbGeAlD
Tacrolimus—PPP3CA—female gonad—hypothyroidism	0.00215	0.0177	CbGeAlD
Tacrolimus—FKBP1A—adrenal cortex—hypothyroidism	0.00212	0.0174	CbGeAlD
Tacrolimus—Acute coronary syndrome—Liothyronine—hypothyroidism	0.0021	0.00936	CcSEcCtD
Tacrolimus—Myocardial infarction—Liothyronine—hypothyroidism	0.00208	0.0093	CcSEcCtD
Tacrolimus—FKBP1A—heart—hypothyroidism	0.00205	0.0169	CbGeAlD
Tacrolimus—Intestinal obstruction—Liotrix—hypothyroidism	0.00201	0.00899	CcSEcCtD
Tacrolimus—MTOR—gonad—hypothyroidism	0.00196	0.0161	CbGeAlD
Tacrolimus—FKBP1A—cardiovascular system—hypothyroidism	0.00194	0.0159	CbGeAlD
Tacrolimus—PPP3CA—testis—hypothyroidism	0.00191	0.0157	CbGeAlD
Tacrolimus—MTOR—pituitary gland—hypothyroidism	0.00191	0.0157	CbGeAlD
Tacrolimus—PPP3CA—liver—hypothyroidism	0.0018	0.0148	CbGeAlD
Tacrolimus—Coagulopathy—Liotrix—hypothyroidism	0.00176	0.00787	CcSEcCtD
Tacrolimus—PPP3CA—cerebellum—hypothyroidism	0.00176	0.0145	CbGeAlD
Tacrolimus—FKBP1A—gonad—hypothyroidism	0.00176	0.0145	CbGeAlD
Tacrolimus—Feeling hot—Liotrix—hypothyroidism	0.00175	0.00781	CcSEcCtD
Tacrolimus—Abscess—Liotrix—hypothyroidism	0.00173	0.00775	CcSEcCtD
Tacrolimus—FKBP1A—pituitary gland—hypothyroidism	0.00172	0.0141	CbGeAlD
Tacrolimus—Coma—Levothyroxine—hypothyroidism	0.00171	0.00761	CcSEcCtD
Tacrolimus—Coma—Dextrothyroxine—hypothyroidism	0.00171	0.00761	CcSEcCtD
Tacrolimus—Arrhythmia—Liothyronine—hypothyroidism	0.0017	0.00761	CcSEcCtD
Tacrolimus—MTOR—adrenal gland—hypothyroidism	0.0017	0.014	CbGeAlD
Tacrolimus—MTOR—blood—hypothyroidism	0.0017	0.014	CbGeAlD
Tacrolimus—MTOR—thyroid gland—hypothyroidism	0.00164	0.0135	CbGeAlD
Tacrolimus—MTOR—female gonad—hypothyroidism	0.00159	0.0131	CbGeAlD
Tacrolimus—FKBP1A—adrenal gland—hypothyroidism	0.00153	0.0126	CbGeAlD
Tacrolimus—FKBP1A—blood—hypothyroidism	0.00153	0.0126	CbGeAlD
Tacrolimus—Disorientation—Dextrothyroxine—hypothyroidism	0.00151	0.00676	CcSEcCtD
Tacrolimus—Disorientation—Levothyroxine—hypothyroidism	0.00151	0.00676	CcSEcCtD
Tacrolimus—Cellulitis—Liotrix—hypothyroidism	0.00151	0.00674	CcSEcCtD
Tacrolimus—Hypocalcaemia—Liotrix—hypothyroidism	0.0015	0.00669	CcSEcCtD
Tacrolimus—Cardiac failure congestive—Levothyroxine—hypothyroidism	0.00149	0.00667	CcSEcCtD
Tacrolimus—Cardiac failure congestive—Dextrothyroxine—hypothyroidism	0.00149	0.00667	CcSEcCtD
Tacrolimus—Oliguria—Liotrix—hypothyroidism	0.00149	0.00665	CcSEcCtD
Tacrolimus—CYP3A7—liver—hypothyroidism	0.00148	0.0122	CbGeAlD
Tacrolimus—FKBP1A—thyroid gland—hypothyroidism	0.00148	0.0122	CbGeAlD
Tacrolimus—Ulcer—Liotrix—hypothyroidism	0.00145	0.00648	CcSEcCtD
Tacrolimus—Creatinine increased—Liotrix—hypothyroidism	0.00144	0.00644	CcSEcCtD
Tacrolimus—Increased appetite—Levothyroxine—hypothyroidism	0.00144	0.00644	CcSEcCtD
Tacrolimus—Increased appetite—Dextrothyroxine—hypothyroidism	0.00144	0.00644	CcSEcCtD
Tacrolimus—Hypertension—Liothyronine—hypothyroidism	0.00143	0.0064	CcSEcCtD
Tacrolimus—FKBP1A—female gonad—hypothyroidism	0.00143	0.0117	CbGeAlD
Tacrolimus—ALB—heart—hypothyroidism	0.00141	0.0116	CbGeAlD
Tacrolimus—MTOR—testis—hypothyroidism	0.00141	0.0116	CbGeAlD
Tacrolimus—PPP3CA—FCERI mediated Ca+2 mobilization—VAV3—hypothyroidism	0.00141	0.044	CbGpPWpGaD
Tacrolimus—Hypoglycaemia—Levothyroxine—hypothyroidism	0.00139	0.0062	CcSEcCtD
Tacrolimus—Cardiac failure—Dextrothyroxine—hypothyroidism	0.00139	0.0062	CcSEcCtD
Tacrolimus—Hypoglycaemia—Dextrothyroxine—hypothyroidism	0.00139	0.0062	CcSEcCtD
Tacrolimus—Cardiac failure—Levothyroxine—hypothyroidism	0.00139	0.0062	CcSEcCtD
Tacrolimus—Affect lability—Dextrothyroxine—hypothyroidism	0.00133	0.00595	CcSEcCtD
Tacrolimus—Affect lability—Levothyroxine—hypothyroidism	0.00133	0.00595	CcSEcCtD
Tacrolimus—MTOR—liver—hypothyroidism	0.00133	0.0109	CbGeAlD
Tacrolimus—Tachycardia—Liothyronine—hypothyroidism	0.00132	0.00591	CcSEcCtD
Tacrolimus—Fluid retention—Liotrix—hypothyroidism	0.0013	0.00582	CcSEcCtD
Tacrolimus—MTOR—cerebellum—hypothyroidism	0.0013	0.0107	CbGeAlD
Tacrolimus—Blood urea increased—Liotrix—hypothyroidism	0.0013	0.00579	CcSEcCtD
Tacrolimus—Cardiac arrest—Levothyroxine—hypothyroidism	0.00129	0.00575	CcSEcCtD
Tacrolimus—Cardiac arrest—Dextrothyroxine—hypothyroidism	0.00129	0.00575	CcSEcCtD
Tacrolimus—Mood swings—Levothyroxine—hypothyroidism	0.00128	0.00573	CcSEcCtD
Tacrolimus—Mood swings—Dextrothyroxine—hypothyroidism	0.00128	0.00573	CcSEcCtD
Tacrolimus—FKBP1A—testis—hypothyroidism	0.00127	0.0104	CbGeAlD
Tacrolimus—Hypotension—Liothyronine—hypothyroidism	0.00127	0.00566	CcSEcCtD
Tacrolimus—CYP3A7-CYP3A51P—liver—hypothyroidism	0.00126	0.0104	CbGeAlD
Tacrolimus—Dehydration—Dextrothyroxine—hypothyroidism	0.00126	0.00562	CcSEcCtD
Tacrolimus—Dehydration—Levothyroxine—hypothyroidism	0.00126	0.00562	CcSEcCtD
Tacrolimus—Coma—Liotrix—hypothyroidism	0.00125	0.0056	CcSEcCtD
Tacrolimus—ORM1—blood—hypothyroidism	0.0012	0.00986	CbGeAlD
Tacrolimus—FKBP1A—liver—hypothyroidism	0.0012	0.00985	CbGeAlD
Tacrolimus—Muscular weakness—Levothyroxine—hypothyroidism	0.00119	0.00533	CcSEcCtD
Tacrolimus—Muscular weakness—Dextrothyroxine—hypothyroidism	0.00119	0.00533	CcSEcCtD
Tacrolimus—MTOR—TSH signaling pathway—PAX8—hypothyroidism	0.00119	0.0373	CbGpPWpGaD
Tacrolimus—Sepsis—Liotrix—hypothyroidism	0.00119	0.00532	CcSEcCtD
Tacrolimus—FKBP1A—cerebellum—hypothyroidism	0.00117	0.00962	CbGeAlD
Tacrolimus—Dysphagia—Dextrothyroxine—hypothyroidism	0.00117	0.00523	CcSEcCtD
Tacrolimus—Dysphagia—Levothyroxine—hypothyroidism	0.00117	0.00523	CcSEcCtD
Tacrolimus—Phlebitis—Liotrix—hypothyroidism	0.00116	0.00516	CcSEcCtD
Tacrolimus—Angina pectoris—Levothyroxine—hypothyroidism	0.00114	0.00509	CcSEcCtD
Tacrolimus—Sweating increased—Levothyroxine—hypothyroidism	0.00114	0.00509	CcSEcCtD
Tacrolimus—Angina pectoris—Dextrothyroxine—hypothyroidism	0.00114	0.00509	CcSEcCtD
Tacrolimus—Sweating increased—Dextrothyroxine—hypothyroidism	0.00114	0.00509	CcSEcCtD
Tacrolimus—Disorientation—Liotrix—hypothyroidism	0.00111	0.00497	CcSEcCtD
Tacrolimus—Cardiac failure congestive—Liotrix—hypothyroidism	0.0011	0.00491	CcSEcCtD
Tacrolimus—Renal failure acute—Liotrix—hypothyroidism	0.00108	0.00482	CcSEcCtD
Tacrolimus—Body temperature increased—Liothyronine—hypothyroidism	0.00107	0.00479	CcSEcCtD
Tacrolimus—Increased appetite—Liotrix—hypothyroidism	0.00106	0.00474	CcSEcCtD
Tacrolimus—Weight decreased—Levothyroxine—hypothyroidism	0.00106	0.00473	CcSEcCtD
Tacrolimus—Weight decreased—Dextrothyroxine—hypothyroidism	0.00106	0.00473	CcSEcCtD
Tacrolimus—ALB—adrenal gland—hypothyroidism	0.00105	0.00865	CbGeAlD
Tacrolimus—Renal impairment—Liotrix—hypothyroidism	0.00105	0.00467	CcSEcCtD
Tacrolimus—Acute coronary syndrome—Dextrothyroxine—hypothyroidism	0.00103	0.00459	CcSEcCtD
Tacrolimus—Acute coronary syndrome—Levothyroxine—hypothyroidism	0.00103	0.00459	CcSEcCtD
Tacrolimus—Myocardial infarction—Levothyroxine—hypothyroidism	0.00102	0.00457	CcSEcCtD
Tacrolimus—Myocardial infarction—Dextrothyroxine—hypothyroidism	0.00102	0.00457	CcSEcCtD
Tacrolimus—Cardiac failure—Liotrix—hypothyroidism	0.00102	0.00456	CcSEcCtD
Tacrolimus—Hypoglycaemia—Liotrix—hypothyroidism	0.00102	0.00456	CcSEcCtD
Tacrolimus—Sweating—Dextrothyroxine—hypothyroidism	0.001	0.00447	CcSEcCtD
Tacrolimus—Sweating—Levothyroxine—hypothyroidism	0.001	0.00447	CcSEcCtD
Tacrolimus—Affect lability—Liotrix—hypothyroidism	0.000981	0.00438	CcSEcCtD
Tacrolimus—Cardiac arrest—Liotrix—hypothyroidism	0.000947	0.00423	CcSEcCtD
Tacrolimus—Mood swings—Liotrix—hypothyroidism	0.000944	0.00421	CcSEcCtD
Tacrolimus—ORM1—liver—hypothyroidism	0.000938	0.00771	CbGeAlD
Tacrolimus—Blood creatinine increased—Liotrix—hypothyroidism	0.000933	0.00417	CcSEcCtD
Tacrolimus—Dehydration—Liotrix—hypothyroidism	0.000927	0.00414	CcSEcCtD
Tacrolimus—Hypokalaemia—Liotrix—hypothyroidism	0.000907	0.00405	CcSEcCtD
Tacrolimus—Muscular weakness—Liotrix—hypothyroidism	0.000879	0.00392	CcSEcCtD
Tacrolimus—ALB—testis—hypothyroidism	0.00087	0.00715	CbGeAlD
Tacrolimus—Flushing—Dextrothyroxine—hypothyroidism	0.00087	0.00388	CcSEcCtD
Tacrolimus—Flushing—Levothyroxine—hypothyroidism	0.00087	0.00388	CcSEcCtD
Tacrolimus—Abdominal distension—Liotrix—hypothyroidism	0.000867	0.00387	CcSEcCtD
Tacrolimus—Dysphagia—Liotrix—hypothyroidism	0.000861	0.00385	CcSEcCtD
Tacrolimus—Angina pectoris—Liotrix—hypothyroidism	0.000839	0.00375	CcSEcCtD
Tacrolimus—Sweating increased—Liotrix—hypothyroidism	0.000839	0.00375	CcSEcCtD
Tacrolimus—Arrhythmia—Dextrothyroxine—hypothyroidism	0.000837	0.00374	CcSEcCtD
Tacrolimus—Arrhythmia—Levothyroxine—hypothyroidism	0.000837	0.00374	CcSEcCtD
Tacrolimus—PPP3CA—beta-catenin independent WNT signaling—CLTC—hypothyroidism	0.000833	0.026	CbGpPWpGaD
Tacrolimus—Bronchitis—Liotrix—hypothyroidism	0.000828	0.0037	CcSEcCtD
Tacrolimus—Alopecia—Dextrothyroxine—hypothyroidism	0.000828	0.0037	CcSEcCtD
Tacrolimus—Alopecia—Levothyroxine—hypothyroidism	0.000828	0.0037	CcSEcCtD
Tacrolimus—ALB—liver—hypothyroidism	0.000823	0.00676	CbGeAlD
Tacrolimus—Tension—Levothyroxine—hypothyroidism	0.000801	0.00357	CcSEcCtD
Tacrolimus—Tension—Dextrothyroxine—hypothyroidism	0.000801	0.00357	CcSEcCtD
Tacrolimus—Nervousness—Dextrothyroxine—hypothyroidism	0.000792	0.00354	CcSEcCtD
Tacrolimus—Nervousness—Levothyroxine—hypothyroidism	0.000792	0.00354	CcSEcCtD
Tacrolimus—Weight decreased—Liotrix—hypothyroidism	0.000779	0.00348	CcSEcCtD
Tacrolimus—Tremor—Dextrothyroxine—hypothyroidism	0.000764	0.00341	CcSEcCtD
Tacrolimus—Tremor—Levothyroxine—hypothyroidism	0.000764	0.00341	CcSEcCtD
Tacrolimus—Acute coronary syndrome—Liotrix—hypothyroidism	0.000757	0.00338	CcSEcCtD
Tacrolimus—Renal failure—Liotrix—hypothyroidism	0.000755	0.00337	CcSEcCtD
Tacrolimus—Myocardial infarction—Liotrix—hypothyroidism	0.000753	0.00336	CcSEcCtD
Tacrolimus—Agitation—Dextrothyroxine—hypothyroidism	0.00075	0.00335	CcSEcCtD
Tacrolimus—Agitation—Levothyroxine—hypothyroidism	0.00075	0.00335	CcSEcCtD
Tacrolimus—Sweating—Liotrix—hypothyroidism	0.000736	0.00329	CcSEcCtD
Tacrolimus—Palpitations—Levothyroxine—hypothyroidism	0.000721	0.00322	CcSEcCtD
Tacrolimus—Palpitations—Dextrothyroxine—hypothyroidism	0.000721	0.00322	CcSEcCtD
Tacrolimus—Convulsion—Dextrothyroxine—hypothyroidism	0.000707	0.00316	CcSEcCtD
Tacrolimus—Convulsion—Levothyroxine—hypothyroidism	0.000707	0.00316	CcSEcCtD
Tacrolimus—Arthralgia—Levothyroxine—hypothyroidism	0.000695	0.0031	CcSEcCtD
Tacrolimus—Arthralgia—Dextrothyroxine—hypothyroidism	0.000695	0.0031	CcSEcCtD
Tacrolimus—Anxiety—Dextrothyroxine—hypothyroidism	0.000692	0.00309	CcSEcCtD
Tacrolimus—Anxiety—Levothyroxine—hypothyroidism	0.000692	0.00309	CcSEcCtD
Tacrolimus—Hypoaesthesia—Liotrix—hypothyroidism	0.000686	0.00306	CcSEcCtD
Tacrolimus—Confusional state—Dextrothyroxine—hypothyroidism	0.000671	0.003	CcSEcCtD
Tacrolimus—Confusional state—Levothyroxine—hypothyroidism	0.000671	0.003	CcSEcCtD
Tacrolimus—CYP3A5—blood—hypothyroidism	0.000667	0.00548	CbGeAlD
Tacrolimus—Shock—Dextrothyroxine—hypothyroidism	0.000655	0.00292	CcSEcCtD
Tacrolimus—Shock—Levothyroxine—hypothyroidism	0.000655	0.00292	CcSEcCtD
Tacrolimus—Tachycardia—Levothyroxine—hypothyroidism	0.00065	0.0029	CcSEcCtD
Tacrolimus—Tachycardia—Dextrothyroxine—hypothyroidism	0.00065	0.0029	CcSEcCtD
Tacrolimus—Hyperhidrosis—Levothyroxine—hypothyroidism	0.000644	0.00287	CcSEcCtD
Tacrolimus—Hyperhidrosis—Dextrothyroxine—hypothyroidism	0.000644	0.00287	CcSEcCtD
Tacrolimus—Flushing—Liotrix—hypothyroidism	0.00064	0.00286	CcSEcCtD
Tacrolimus—MTOR—VEGFR2 mediated vascular permeability—VAV3—hypothyroidism	0.000631	0.0197	CbGpPWpGaD
Tacrolimus—ALB—Transport of organic anions—AVP—hypothyroidism	0.00063	0.0197	CbGpPWpGaD
Tacrolimus—CYP3A5—female gonad—hypothyroidism	0.000622	0.00511	CbGeAlD
Tacrolimus—Arrhythmia—Liotrix—hypothyroidism	0.000616	0.00275	CcSEcCtD
Tacrolimus—Alopecia—Liotrix—hypothyroidism	0.000609	0.00272	CcSEcCtD
Tacrolimus—Musculoskeletal discomfort—Levothyroxine—hypothyroidism	0.000607	0.00271	CcSEcCtD
Tacrolimus—Musculoskeletal discomfort—Dextrothyroxine—hypothyroidism	0.000607	0.00271	CcSEcCtD
Tacrolimus—Insomnia—Levothyroxine—hypothyroidism	0.000602	0.00269	CcSEcCtD
Tacrolimus—Insomnia—Dextrothyroxine—hypothyroidism	0.000602	0.00269	CcSEcCtD
Tacrolimus—Dyspnoea—Dextrothyroxine—hypothyroidism	0.000594	0.00265	CcSEcCtD
Tacrolimus—Dyspnoea—Levothyroxine—hypothyroidism	0.000594	0.00265	CcSEcCtD
Tacrolimus—Flatulence—Liotrix—hypothyroidism	0.000591	0.00264	CcSEcCtD
Tacrolimus—Tension—Liotrix—hypothyroidism	0.000589	0.00263	CcSEcCtD
Tacrolimus—Dysgeusia—Liotrix—hypothyroidism	0.000588	0.00262	CcSEcCtD
Tacrolimus—Nervousness—Liotrix—hypothyroidism	0.000583	0.0026	CcSEcCtD
Tacrolimus—Fatigue—Levothyroxine—hypothyroidism	0.000574	0.00256	CcSEcCtD
Tacrolimus—Fatigue—Dextrothyroxine—hypothyroidism	0.000574	0.00256	CcSEcCtD
Tacrolimus—Vision blurred—Liotrix—hypothyroidism	0.000566	0.00253	CcSEcCtD
Tacrolimus—Tremor—Liotrix—hypothyroidism	0.000562	0.00251	CcSEcCtD
Tacrolimus—Agitation—Liotrix—hypothyroidism	0.000551	0.00246	CcSEcCtD
Tacrolimus—Feeling abnormal—Dextrothyroxine—hypothyroidism	0.000549	0.00245	CcSEcCtD
Tacrolimus—Feeling abnormal—Levothyroxine—hypothyroidism	0.000549	0.00245	CcSEcCtD
Tacrolimus—ALB—FOXA2 and FOXA3 transcription factor networks—NKX2-1—hypothyroidism	0.000548	0.0171	CbGpPWpGaD
Tacrolimus—Gastrointestinal pain—Levothyroxine—hypothyroidism	0.000544	0.00243	CcSEcCtD
Tacrolimus—Gastrointestinal pain—Dextrothyroxine—hypothyroidism	0.000544	0.00243	CcSEcCtD
Tacrolimus—Syncope—Liotrix—hypothyroidism	0.000538	0.0024	CcSEcCtD
Tacrolimus—Palpitations—Liotrix—hypothyroidism	0.00053	0.00237	CcSEcCtD
Tacrolimus—Urticaria—Levothyroxine—hypothyroidism	0.000529	0.00236	CcSEcCtD
Tacrolimus—Urticaria—Dextrothyroxine—hypothyroidism	0.000529	0.00236	CcSEcCtD
Tacrolimus—Loss of consciousness—Liotrix—hypothyroidism	0.000527	0.00235	CcSEcCtD
Tacrolimus—Body temperature increased—Dextrothyroxine—hypothyroidism	0.000526	0.00235	CcSEcCtD
Tacrolimus—Abdominal pain—Dextrothyroxine—hypothyroidism	0.000526	0.00235	CcSEcCtD
Tacrolimus—Body temperature increased—Levothyroxine—hypothyroidism	0.000526	0.00235	CcSEcCtD
Tacrolimus—Abdominal pain—Levothyroxine—hypothyroidism	0.000526	0.00235	CcSEcCtD
Tacrolimus—CYP3A5—liver—hypothyroidism	0.000522	0.00429	CbGeAlD
Tacrolimus—Convulsion—Liotrix—hypothyroidism	0.00052	0.00232	CcSEcCtD
Tacrolimus—MTOR—TSH signaling pathway—TSHB—hypothyroidism	0.000519	0.0162	CbGpPWpGaD
Tacrolimus—MTOR—TSH signaling pathway—TSHR—hypothyroidism	0.000519	0.0162	CbGpPWpGaD
Tacrolimus—PPP3CA—Cardiac Hypertrophic Response—IGF1—hypothyroidism	0.000519	0.0162	CbGpPWpGaD
Tacrolimus—Hypertension—Liotrix—hypothyroidism	0.000518	0.00231	CcSEcCtD
Tacrolimus—Arthralgia—Liotrix—hypothyroidism	0.000511	0.00228	CcSEcCtD
Tacrolimus—Chest pain—Liotrix—hypothyroidism	0.000511	0.00228	CcSEcCtD
Tacrolimus—Anxiety—Liotrix—hypothyroidism	0.000509	0.00227	CcSEcCtD
Tacrolimus—CYP3A4—blood—hypothyroidism	0.000501	0.00412	CbGeAlD
Tacrolimus—Confusional state—Liotrix—hypothyroidism	0.000494	0.0022	CcSEcCtD
Tacrolimus—ABCB1—adrenal cortex—hypothyroidism	0.000491	0.00404	CbGeAlD
Tacrolimus—Oedema—Liotrix—hypothyroidism	0.00049	0.00219	CcSEcCtD
Tacrolimus—Anaphylactic shock—Liotrix—hypothyroidism	0.00049	0.00219	CcSEcCtD
Tacrolimus—Infection—Liotrix—hypothyroidism	0.000487	0.00217	CcSEcCtD
Tacrolimus—Shock—Liotrix—hypothyroidism	0.000482	0.00215	CcSEcCtD
Tacrolimus—Tachycardia—Liotrix—hypothyroidism	0.000478	0.00213	CcSEcCtD
Tacrolimus—Asthenia—Dextrothyroxine—hypothyroidism	0.000478	0.00213	CcSEcCtD
Tacrolimus—Asthenia—Levothyroxine—hypothyroidism	0.000478	0.00213	CcSEcCtD
Tacrolimus—ABCB1—heart—hypothyroidism	0.000475	0.0039	CbGeAlD
Tacrolimus—Hyperhidrosis—Liotrix—hypothyroidism	0.000473	0.00211	CcSEcCtD
Tacrolimus—Pruritus—Levothyroxine—hypothyroidism	0.000471	0.0021	CcSEcCtD
Tacrolimus—Pruritus—Dextrothyroxine—hypothyroidism	0.000471	0.0021	CcSEcCtD
Tacrolimus—Anorexia—Liotrix—hypothyroidism	0.000467	0.00208	CcSEcCtD
Tacrolimus—Hypotension—Liotrix—hypothyroidism	0.000458	0.00204	CcSEcCtD
Tacrolimus—Diarrhoea—Levothyroxine—hypothyroidism	0.000456	0.00203	CcSEcCtD
Tacrolimus—Diarrhoea—Dextrothyroxine—hypothyroidism	0.000456	0.00203	CcSEcCtD
Tacrolimus—ABCB1—cardiovascular system—hypothyroidism	0.000448	0.00368	CbGeAlD
Tacrolimus—Musculoskeletal discomfort—Liotrix—hypothyroidism	0.000446	0.00199	CcSEcCtD
Tacrolimus—Insomnia—Liotrix—hypothyroidism	0.000443	0.00198	CcSEcCtD
Tacrolimus—PPP3CA—Signaling by Wnt—CLTC—hypothyroidism	0.00044	0.0138	CbGpPWpGaD
Tacrolimus—Paraesthesia—Liotrix—hypothyroidism	0.00044	0.00196	CcSEcCtD
Tacrolimus—Dyspnoea—Liotrix—hypothyroidism	0.000437	0.00195	CcSEcCtD
Tacrolimus—Decreased appetite—Liotrix—hypothyroidism	0.000426	0.0019	CcSEcCtD
Tacrolimus—Vomiting—Dextrothyroxine—hypothyroidism	0.000423	0.00189	CcSEcCtD
Tacrolimus—Vomiting—Levothyroxine—hypothyroidism	0.000423	0.00189	CcSEcCtD
Tacrolimus—Fatigue—Liotrix—hypothyroidism	0.000422	0.00189	CcSEcCtD
Tacrolimus—Rash—Levothyroxine—hypothyroidism	0.00042	0.00187	CcSEcCtD
Tacrolimus—Rash—Dextrothyroxine—hypothyroidism	0.00042	0.00187	CcSEcCtD
Tacrolimus—Dermatitis—Dextrothyroxine—hypothyroidism	0.000419	0.00187	CcSEcCtD
Tacrolimus—Dermatitis—Levothyroxine—hypothyroidism	0.000419	0.00187	CcSEcCtD
Tacrolimus—Constipation—Liotrix—hypothyroidism	0.000419	0.00187	CcSEcCtD
Tacrolimus—Headache—Levothyroxine—hypothyroidism	0.000417	0.00186	CcSEcCtD
Tacrolimus—Headache—Dextrothyroxine—hypothyroidism	0.000417	0.00186	CcSEcCtD
Tacrolimus—ABCB1—gonad—hypothyroidism	0.000407	0.00334	CbGeAlD
Tacrolimus—Feeling abnormal—Liotrix—hypothyroidism	0.000404	0.0018	CcSEcCtD
Tacrolimus—Gastrointestinal pain—Liotrix—hypothyroidism	0.0004	0.00179	CcSEcCtD
Tacrolimus—ABCB1—pituitary gland—hypothyroidism	0.000397	0.00326	CbGeAlD
Tacrolimus—PPP3CA—Opioid Signalling—POMC—hypothyroidism	0.000396	0.0124	CbGpPWpGaD
Tacrolimus—Nausea—Levothyroxine—hypothyroidism	0.000395	0.00177	CcSEcCtD
Tacrolimus—Nausea—Dextrothyroxine—hypothyroidism	0.000395	0.00177	CcSEcCtD
Tacrolimus—CYP3A4—liver—hypothyroidism	0.000392	0.00322	CbGeAlD
Tacrolimus—Urticaria—Liotrix—hypothyroidism	0.000389	0.00174	CcSEcCtD
Tacrolimus—Abdominal pain—Liotrix—hypothyroidism	0.000387	0.00173	CcSEcCtD
Tacrolimus—Body temperature increased—Liotrix—hypothyroidism	0.000387	0.00173	CcSEcCtD
Tacrolimus—PPP3CA—MicroRNAs in cardiomyocyte hypertrophy—IGF1—hypothyroidism	0.00037	0.0116	CbGpPWpGaD
Tacrolimus—Hypersensitivity—Liotrix—hypothyroidism	0.000361	0.00161	CcSEcCtD
Tacrolimus—ABCB1—adrenal gland—hypothyroidism	0.000355	0.00291	CbGeAlD
Tacrolimus—ABCB1—blood—hypothyroidism	0.000355	0.00291	CbGeAlD
Tacrolimus—Asthenia—Liotrix—hypothyroidism	0.000351	0.00157	CcSEcCtD
Tacrolimus—Pruritus—Liotrix—hypothyroidism	0.000346	0.00155	CcSEcCtD
Tacrolimus—ABCB1—thyroid gland—hypothyroidism	0.000342	0.00281	CbGeAlD
Tacrolimus—Diarrhoea—Liotrix—hypothyroidism	0.000335	0.0015	CcSEcCtD
Tacrolimus—PPP3CA—Fc epsilon receptor (FCERI) signaling—VAV3—hypothyroidism	0.000331	0.0103	CbGpPWpGaD
Tacrolimus—ABCB1—female gonad—hypothyroidism	0.000331	0.00272	CbGeAlD
Tacrolimus—Dizziness—Liotrix—hypothyroidism	0.000324	0.00145	CcSEcCtD
Tacrolimus—Vomiting—Liotrix—hypothyroidism	0.000311	0.00139	CcSEcCtD
Tacrolimus—Rash—Liotrix—hypothyroidism	0.000309	0.00138	CcSEcCtD
Tacrolimus—Dermatitis—Liotrix—hypothyroidism	0.000309	0.00138	CcSEcCtD
Tacrolimus—Headache—Liotrix—hypothyroidism	0.000307	0.00137	CcSEcCtD
Tacrolimus—ABCB1—testis—hypothyroidism	0.000293	0.00241	CbGeAlD
Tacrolimus—Nausea—Liotrix—hypothyroidism	0.000291	0.0013	CcSEcCtD
Tacrolimus—ABCB1—liver—hypothyroidism	0.000277	0.00228	CbGeAlD
Tacrolimus—ABCB1—cerebellum—hypothyroidism	0.000271	0.00223	CbGeAlD
Tacrolimus—MTOR—Signaling by SCF-KIT—SH2B3—hypothyroidism	0.000252	0.00788	CbGpPWpGaD
Tacrolimus—ALB—Transport of vitamins, nucleosides, and related molecules—AVP—hypothyroidism	0.000234	0.00731	CbGpPWpGaD
Tacrolimus—MTOR—Insulin Signaling—PIK3C2A—hypothyroidism	0.000228	0.00713	CbGpPWpGaD
Tacrolimus—MTOR—Cardiac Hypertrophic Response—IGF1—hypothyroidism	0.000226	0.00708	CbGpPWpGaD
Tacrolimus—MTOR—VEGFA-VEGFR2 Pathway—VAV3—hypothyroidism	0.000216	0.00675	CbGpPWpGaD
Tacrolimus—MTOR—Signaling by VEGF—VAV3—hypothyroidism	0.000204	0.00637	CbGpPWpGaD
Tacrolimus—MTOR—Signaling by ERBB4—PRL—hypothyroidism	0.000176	0.00551	CbGpPWpGaD
Tacrolimus—CYP3A7—Cytochrome P450 - arranged by substrate type—POMC—hypothyroidism	0.000173	0.00542	CbGpPWpGaD
Tacrolimus—MTOR—BDNF signaling pathway—VAV3—hypothyroidism	0.00017	0.00532	CbGpPWpGaD
Tacrolimus—MTOR—MicroRNAs in cardiomyocyte hypertrophy—IGF1—hypothyroidism	0.000161	0.00504	CbGpPWpGaD
Tacrolimus—ALB—SLC-mediated transmembrane transport—SLC5A7—hypothyroidism	0.00016	0.00499	CbGpPWpGaD
Tacrolimus—PPP3CA—Immune System—CLTC—hypothyroidism	0.000159	0.00497	CbGpPWpGaD
Tacrolimus—MTOR—EGF/EGFR Signaling Pathway—VAV3—hypothyroidism	0.000155	0.00484	CbGpPWpGaD
Tacrolimus—MTOR—IRS-related events triggered by IGF1R—IGF1—hypothyroidism	0.000154	0.00482	CbGpPWpGaD
Tacrolimus—MTOR—DAP12 signaling—VAV3—hypothyroidism	0.000153	0.0048	CbGpPWpGaD
Tacrolimus—PPP3CA—Signaling by GPCR—TRH—hypothyroidism	0.00015	0.0047	CbGpPWpGaD
Tacrolimus—MTOR—IGF1R signaling cascade—IGF1—hypothyroidism	0.00015	0.00469	CbGpPWpGaD
Tacrolimus—FKBP1A—Integrated Pancreatic Cancer Pathway—IGF1—hypothyroidism	0.000149	0.00465	CbGpPWpGaD
Tacrolimus—MTOR—DAP12 interactions—VAV3—hypothyroidism	0.000144	0.00451	CbGpPWpGaD
Tacrolimus—MTOR—Fc epsilon receptor (FCERI) signaling—VAV3—hypothyroidism	0.000144	0.00451	CbGpPWpGaD
Tacrolimus—CYP3A7—Phase 1 - Functionalization of compounds—POMC—hypothyroidism	0.00014	0.00439	CbGpPWpGaD
Tacrolimus—MTOR—Senescence and Autophagy in Cancer—IGF1—hypothyroidism	0.000135	0.00422	CbGpPWpGaD
Tacrolimus—PPP3CA—Signaling by GPCR—TSHB—hypothyroidism	0.000134	0.00419	CbGpPWpGaD
Tacrolimus—PPP3CA—Signaling by GPCR—TSHR—hypothyroidism	0.000134	0.00419	CbGpPWpGaD
Tacrolimus—ALB—SLC-mediated transmembrane transport—SLC26A4—hypothyroidism	0.000132	0.00413	CbGpPWpGaD
Tacrolimus—PPP3CA—Innate Immune System—VAV3—hypothyroidism	0.000129	0.00402	CbGpPWpGaD
Tacrolimus—CYP3A5—Cytochrome P450 - arranged by substrate type—POMC—hypothyroidism	0.000125	0.00392	CbGpPWpGaD
Tacrolimus—MTOR—Adaptive Immune System—CLTC—hypothyroidism	0.000114	0.00357	CbGpPWpGaD
Tacrolimus—PPP3CA—Signaling Pathways—CLTC—hypothyroidism	0.000103	0.00321	CbGpPWpGaD
Tacrolimus—CYP3A5—Phase 1 - Functionalization of compounds—POMC—hypothyroidism	0.000101	0.00317	CbGpPWpGaD
Tacrolimus—MTOR—Signaling by NGF—VAV3—hypothyroidism	9.83e-05	0.00307	CbGpPWpGaD
Tacrolimus—PPP3CA—Signaling Pathways—TRH—hypothyroidism	8.88e-05	0.00278	CbGpPWpGaD
Tacrolimus—CYP3A7—Metabolism—IYD—hypothyroidism	8.8e-05	0.00275	CbGpPWpGaD
Tacrolimus—ALB—Platelet degranulation—IGF1—hypothyroidism	8.24e-05	0.00258	CbGpPWpGaD
Tacrolimus—PPP3CA—Signaling by GPCR—VAV3—hypothyroidism	8.19e-05	0.00256	CbGpPWpGaD
Tacrolimus—ALB—Transmembrane transport of small molecules—SLC5A7—hypothyroidism	8.11e-05	0.00254	CbGpPWpGaD
Tacrolimus—PPP3CA—Immune System—PRL—hypothyroidism	8.09e-05	0.00253	CbGpPWpGaD
Tacrolimus—FKBP1A—Signaling Pathways—CLTC—hypothyroidism	7.96e-05	0.00249	CbGpPWpGaD
Tacrolimus—PPP3CA—Signaling Pathways—TSHB—hypothyroidism	7.91e-05	0.00247	CbGpPWpGaD
Tacrolimus—PPP3CA—Signaling Pathways—TSHR—hypothyroidism	7.91e-05	0.00247	CbGpPWpGaD
Tacrolimus—PPP3CA—Signaling by GPCR—AVP—hypothyroidism	7.89e-05	0.00247	CbGpPWpGaD
Tacrolimus—ALB—Response to elevated platelet cytosolic Ca2+—IGF1—hypothyroidism	7.85e-05	0.00245	CbGpPWpGaD
Tacrolimus—PPP3CA—Immune System—VAV3—hypothyroidism	7.49e-05	0.00234	CbGpPWpGaD
Tacrolimus—CYP3A7—Metabolism—ATP5O—hypothyroidism	7.48e-05	0.00234	CbGpPWpGaD
Tacrolimus—PPP3CA—Disease—PRL—hypothyroidism	7.47e-05	0.00234	CbGpPWpGaD
Tacrolimus—CYP3A7—Biological oxidations—POMC—hypothyroidism	7.46e-05	0.00233	CbGpPWpGaD
Tacrolimus—ABCB1—Transmembrane transport of small molecules—SLC5A7—hypothyroidism	7.1e-05	0.00222	CbGpPWpGaD
Tacrolimus—PPP3CA—Signaling Pathways—SH2B3—hypothyroidism	7.05e-05	0.00221	CbGpPWpGaD
Tacrolimus—CYP3A7—Metabolism—TPO—hypothyroidism	7.03e-05	0.0022	CbGpPWpGaD
Tacrolimus—MTOR—Immune System—CLTC—hypothyroidism	6.93e-05	0.00217	CbGpPWpGaD
Tacrolimus—FKBP1A—Signaling Pathways—TRH—hypothyroidism	6.88e-05	0.00215	CbGpPWpGaD
Tacrolimus—ALB—Transmembrane transport of small molecules—SLC26A4—hypothyroidism	6.72e-05	0.0021	CbGpPWpGaD
Tacrolimus—ALB—SLC-mediated transmembrane transport—SLC5A5—hypothyroidism	6.38e-05	0.00199	CbGpPWpGaD
Tacrolimus—CYP3A5—Metabolism—IYD—hypothyroidism	6.36e-05	0.00199	CbGpPWpGaD
Tacrolimus—FKBP1A—Signaling Pathways—TSHB—hypothyroidism	6.13e-05	0.00192	CbGpPWpGaD
Tacrolimus—FKBP1A—Signaling Pathways—TSHR—hypothyroidism	6.13e-05	0.00192	CbGpPWpGaD
Tacrolimus—ALB—Platelet activation, signaling and aggregation—VAV3—hypothyroidism	5.93e-05	0.00186	CbGpPWpGaD
Tacrolimus—ABCB1—Transmembrane transport of small molecules—SLC26A4—hypothyroidism	5.89e-05	0.00184	CbGpPWpGaD
Tacrolimus—CYP3A4—Cytochrome P450 - arranged by substrate type—POMC—hypothyroidism	5.82e-05	0.00182	CbGpPWpGaD
Tacrolimus—FKBP1A—Disease—PRL—hypothyroidism	5.79e-05	0.00181	CbGpPWpGaD
Tacrolimus—MTOR—Innate Immune System—VAV3—hypothyroidism	5.6e-05	0.00175	CbGpPWpGaD
Tacrolimus—ALB—Metabolism—IYD—hypothyroidism	5.48e-05	0.00171	CbGpPWpGaD
Tacrolimus—FKBP1A—Signaling Pathways—SH2B3—hypothyroidism	5.47e-05	0.00171	CbGpPWpGaD
Tacrolimus—CYP3A5—Metabolism—ATP5O—hypothyroidism	5.41e-05	0.00169	CbGpPWpGaD
Tacrolimus—CYP3A5—Biological oxidations—POMC—hypothyroidism	5.39e-05	0.00169	CbGpPWpGaD
Tacrolimus—PPP3CA—Signaling by GPCR—POMC—hypothyroidism	5.25e-05	0.00164	CbGpPWpGaD
Tacrolimus—PPP3CA—Signaling Pathways—PRL—hypothyroidism	5.23e-05	0.00164	CbGpPWpGaD
Tacrolimus—CYP3A5—Metabolism—TPO—hypothyroidism	5.08e-05	0.00159	CbGpPWpGaD
Tacrolimus—ALB—SLC-mediated transmembrane transport—AVP—hypothyroidism	5.02e-05	0.00157	CbGpPWpGaD
Tacrolimus—PPP3CA—Signaling Pathways—VAV3—hypothyroidism	4.84e-05	0.00151	CbGpPWpGaD
Tacrolimus—ABCB1—Metabolism—IYD—hypothyroidism	4.8e-05	0.0015	CbGpPWpGaD
Tacrolimus—CYP3A4—Phase 1 - Functionalization of compounds—POMC—hypothyroidism	4.72e-05	0.00148	CbGpPWpGaD
Tacrolimus—PPP3CA—Signaling Pathways—AVP—hypothyroidism	4.66e-05	0.00146	CbGpPWpGaD
Tacrolimus—ALB—Metabolism—ATP5O—hypothyroidism	4.66e-05	0.00146	CbGpPWpGaD
Tacrolimus—MTOR—Signaling Pathways—CLTC—hypothyroidism	4.48e-05	0.0014	CbGpPWpGaD
Tacrolimus—ALB—Hemostasis—SH2B3—hypothyroidism	4.46e-05	0.00139	CbGpPWpGaD
Tacrolimus—ALB—Metabolism—TPO—hypothyroidism	4.38e-05	0.00137	CbGpPWpGaD
Tacrolimus—ABCB1—Metabolism—ATP5O—hypothyroidism	4.08e-05	0.00128	CbGpPWpGaD
Tacrolimus—ALB—Metabolism of lipids and lipoproteins—PIK3C2A—hypothyroidism	4.06e-05	0.00127	CbGpPWpGaD
Tacrolimus—FKBP1A—Signaling Pathways—PRL—hypothyroidism	4.06e-05	0.00127	CbGpPWpGaD
Tacrolimus—MTOR—Signaling Pathways—TRH—hypothyroidism	3.87e-05	0.00121	CbGpPWpGaD
Tacrolimus—ABCB1—Metabolism—TPO—hypothyroidism	3.84e-05	0.0012	CbGpPWpGaD
Tacrolimus—FKBP1A—Signaling Pathways—VAV3—hypothyroidism	3.75e-05	0.00117	CbGpPWpGaD
Tacrolimus—ALB—Platelet activation, signaling and aggregation—IGF1—hypothyroidism	3.65e-05	0.00114	CbGpPWpGaD
Tacrolimus—FKBP1A—Signaling Pathways—AVP—hypothyroidism	3.62e-05	0.00113	CbGpPWpGaD
Tacrolimus—ABCB1—Integrated Pancreatic Cancer Pathway—IGF1—hypothyroidism	3.6e-05	0.00113	CbGpPWpGaD
Tacrolimus—MTOR—Immune System—PRL—hypothyroidism	3.53e-05	0.0011	CbGpPWpGaD
Tacrolimus—MTOR—Signaling Pathways—TSHB—hypothyroidism	3.45e-05	0.00108	CbGpPWpGaD
Tacrolimus—MTOR—Signaling Pathways—TSHR—hypothyroidism	3.45e-05	0.00108	CbGpPWpGaD
Tacrolimus—MTOR—Immune System—VAV3—hypothyroidism	3.26e-05	0.00102	CbGpPWpGaD
Tacrolimus—MTOR—Disease—PRL—hypothyroidism	3.26e-05	0.00102	CbGpPWpGaD
Tacrolimus—CYP3A7—Metabolism—TSHB—hypothyroidism	3.26e-05	0.00102	CbGpPWpGaD
Tacrolimus—ALB—Transmembrane transport of small molecules—SLC5A5—hypothyroidism	3.24e-05	0.00101	CbGpPWpGaD
Tacrolimus—PPP3CA—Signaling Pathways—POMC—hypothyroidism	3.1e-05	0.000969	CbGpPWpGaD
Tacrolimus—MTOR—Signaling Pathways—SH2B3—hypothyroidism	3.08e-05	0.000962	CbGpPWpGaD
Tacrolimus—ALB—Hemostasis—VAV3—hypothyroidism	3.06e-05	0.000957	CbGpPWpGaD
Tacrolimus—PPP3CA—Signaling Pathways—IGF1—hypothyroidism	2.98e-05	0.000932	CbGpPWpGaD
Tacrolimus—CYP3A4—Metabolism—IYD—hypothyroidism	2.96e-05	0.000925	CbGpPWpGaD
Tacrolimus—CYP3A7—Metabolism—PIK3C2A—hypothyroidism	2.9e-05	0.000908	CbGpPWpGaD
Tacrolimus—ABCB1—Transmembrane transport of small molecules—SLC5A5—hypothyroidism	2.84e-05	0.000888	CbGpPWpGaD
Tacrolimus—ALB—Transmembrane transport of small molecules—AVP—hypothyroidism	2.55e-05	0.000798	CbGpPWpGaD
Tacrolimus—CYP3A4—Metabolism—ATP5O—hypothyroidism	2.51e-05	0.000786	CbGpPWpGaD
Tacrolimus—CYP3A4—Biological oxidations—POMC—hypothyroidism	2.51e-05	0.000784	CbGpPWpGaD
Tacrolimus—CYP3A7—Metabolism—SLC5A5—hypothyroidism	2.44e-05	0.000762	CbGpPWpGaD
Tacrolimus—FKBP1A—Signaling Pathways—POMC—hypothyroidism	2.4e-05	0.000751	CbGpPWpGaD
Tacrolimus—CYP3A4—Metabolism—TPO—hypothyroidism	2.36e-05	0.000739	CbGpPWpGaD
Tacrolimus—CYP3A5—Metabolism—TSHB—hypothyroidism	2.35e-05	0.000736	CbGpPWpGaD
Tacrolimus—FKBP1A—Signaling Pathways—IGF1—hypothyroidism	2.31e-05	0.000723	CbGpPWpGaD
Tacrolimus—MTOR—Signaling Pathways—PRL—hypothyroidism	2.28e-05	0.000714	CbGpPWpGaD
Tacrolimus—ABCB1—Transmembrane transport of small molecules—AVP—hypothyroidism	2.24e-05	0.000699	CbGpPWpGaD
Tacrolimus—MTOR—Signaling Pathways—VAV3—hypothyroidism	2.11e-05	0.00066	CbGpPWpGaD
Tacrolimus—CYP3A5—Metabolism—PIK3C2A—hypothyroidism	2.1e-05	0.000656	CbGpPWpGaD
Tacrolimus—MTOR—Signaling Pathways—AVP—hypothyroidism	2.03e-05	0.000636	CbGpPWpGaD
Tacrolimus—ALB—Metabolism—TSHB—hypothyroidism	2.03e-05	0.000634	CbGpPWpGaD
Tacrolimus—ALB—Hemostasis—IGF1—hypothyroidism	1.88e-05	0.000589	CbGpPWpGaD
Tacrolimus—ALB—Metabolism—PIK3C2A—hypothyroidism	1.81e-05	0.000565	CbGpPWpGaD
Tacrolimus—ALB—Metabolism of lipids and lipoproteins—POMC—hypothyroidism	1.78e-05	0.000558	CbGpPWpGaD
Tacrolimus—ABCB1—Metabolism—TSHB—hypothyroidism	1.78e-05	0.000556	CbGpPWpGaD
Tacrolimus—CYP3A5—Metabolism—SLC5A5—hypothyroidism	1.76e-05	0.000551	CbGpPWpGaD
Tacrolimus—ABCB1—Metabolism—PIK3C2A—hypothyroidism	1.58e-05	0.000495	CbGpPWpGaD
Tacrolimus—ALB—Metabolism—SLC5A5—hypothyroidism	1.52e-05	0.000475	CbGpPWpGaD
Tacrolimus—MTOR—Signaling Pathways—POMC—hypothyroidism	1.35e-05	0.000423	CbGpPWpGaD
Tacrolimus—ABCB1—Metabolism—SLC5A5—hypothyroidism	1.33e-05	0.000416	CbGpPWpGaD
Tacrolimus—MTOR—Signaling Pathways—IGF1—hypothyroidism	1.3e-05	0.000407	CbGpPWpGaD
Tacrolimus—CYP3A7—Metabolism—POMC—hypothyroidism	1.28e-05	0.000399	CbGpPWpGaD
Tacrolimus—CYP3A4—Metabolism—TSHB—hypothyroidism	1.09e-05	0.000342	CbGpPWpGaD
Tacrolimus—CYP3A4—Metabolism—PIK3C2A—hypothyroidism	9.75e-06	0.000305	CbGpPWpGaD
Tacrolimus—CYP3A5—Metabolism—POMC—hypothyroidism	9.22e-06	0.000288	CbGpPWpGaD
Tacrolimus—CYP3A4—Metabolism—SLC5A5—hypothyroidism	8.19e-06	0.000256	CbGpPWpGaD
Tacrolimus—ALB—Metabolism—POMC—hypothyroidism	7.94e-06	0.000248	CbGpPWpGaD
Tacrolimus—ABCB1—Metabolism—POMC—hypothyroidism	6.96e-06	0.000218	CbGpPWpGaD
Tacrolimus—CYP3A4—Metabolism—POMC—hypothyroidism	4.29e-06	0.000134	CbGpPWpGaD
